
|Videos|January 13, 2015
How the DEA Holds Pharmacists Accountable for Failing to Verify Controlled Substance Prescriptions for a Legitimate Purpose
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how the DEA has held pharmacists accountable for failing to verify controlled substance prescriptions for a legitimate medical purpose.
Advertisement
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how the DEA has held pharmacists accountable for failing to verify controlled substance prescriptions for a legitimate medical purpose.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Nufymco, Interchangeable Ranibizumab Biosimilar, for Retinal Diseases
2
Achieving Optimal LDL-C Helps Prevent Neoatherosclerosis, Late Stent Failure in Patients With STEMI
3
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
4
Orforglipron Shows Strong Weight Maintenance in Phase 3 ATTAIN-MAINTAIN Trial
5









































































































































































































